Coya Therapeutics (COYA) Research & Development (2023 - 2025)
Historic Research & Development for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $2.9 million.
- Coya Therapeutics' Research & Development rose 3116.02% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 1901.26%. This contributed to the annual value of $11.9 million for FY2024, which is 11567.93% up from last year.
- Latest data reveals that Coya Therapeutics reported Research & Development of $2.9 million as of Q3 2025, which was up 3116.02% from $3.7 million recorded in Q2 2025.
- In the past 5 years, Coya Therapeutics' Research & Development registered a high of $5.2 million during Q1 2025, and its lowest value of $1.1 million during Q2 2023.
- Over the past 3 years, Coya Therapeutics' median Research & Development value was $2.2 million (recorded in 2024), while the average stood at $2.7 million.
- Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 32756.15% in 2024, then plummeted by 1977.7% in 2025.
- Coya Therapeutics' Research & Development (Quarter) stood at $1.6 million in 2023, then grew by 20.37% to $1.9 million in 2024, then skyrocketed by 50.55% to $2.9 million in 2025.
- Its Research & Development stands at $2.9 million for Q3 2025, versus $3.7 million for Q2 2025 and $5.2 million for Q1 2025.